Currently, there are 415.26M common shares owned by the public and among those 302.36M shares have been available to trade.
The company’s stock has a 5-day price change of 10.49% and 12.80% over the past three months. NYCB shares are trading -61.23% year to date (YTD), with the 12-month market performance down to -62.65% lower. It has a 12-month low price of $5.10 and touched a high of $34.47 over the same period. NYCB has an average intraday trading volume of 6.69 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 5.85%, 10.69%, and -8.13% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of New York Community Bancorp Inc. (NYSE: NYCB) shares accounts for 43.62% of the company’s 415.26M shares outstanding.
It has a market capitalization of $4.94B and a beta (3y monthly) value of 0.99. The earnings-per-share (ttm) stands at -$12.87. The company has a debt-to-equity ratio at 3.39. Price movements for the stock have been influenced by the stock’s volatility, which stands at 4.03% over the week and 4.22% over the month.
Earnings per share for the fiscal year are expected to decrease by -127.84%, and 102.81% over the next financial year.
Looking at the support for the NYCB, a number of firms have released research notes about the stock. Barclays stated their Overweight rating for the stock in a research note on September 26, 2024, with the firm’s price target at $14. Wedbush coverage for the New York Community Bancorp Inc. (NYCB) stock in a research note released on May 01, 2024 offered a Neutral rating with a price target of $3.50. Piper Sandler was of a view on May 01, 2024 that the stock is Overweight, while Raymond James gave the stock Underperform rating on March 18, 2024, issuing a price target of $3. Barclays on their part issued Equal Weight rating on March 08, 2024.
